Guest guest Posted December 2, 2010 Report Share Posted December 2, 2010 Ikaria, Inc. announced that it has enrolled the first patients in its pivotal Phase III trial for LUCASSIN® (terlipressin). The multi-center, randomized, placebo-controlled, double-blind trial is known as the REVERSE Trial. http://www.medicalnewstoday.com/articles/209698.php?nfid=83211 -- Bill Eastman www.ke5asu.com/links.html Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.